LiveKidney.BIO
PrivateLast Round
Seed
Nov 18, 2018
Total Funding Raised
$4M
Company Overview
LiveKidney.BIO operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in November 2018.
LiveKidney.BIO is a biotechnology company that develops proprietary, hydrogel-based cell therapy products to treat advanced kidney diseases and prevent their progression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LiveKidney.BIO Comparables
Compare LiveKidney.BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trestle Biotherapeutics | 85% | |
| eGenesis | 77% | |
| United Therapeutics | 77% |
For institutional investors. Book with your work email.
LiveKidney.BIO Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LiveKidney.BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Direct Insurance - Financial Investments | Seed |
| Aurum Ventures MKI | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors increased 57% MoM.
- Nov 18, 2018
$4M raised from Aurum Ventures MKI and others.
For institutional investors. Book with your work email.
LiveKidney.BIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LiveKidney.BIO's valuation, stock price, and market status.
Is LiveKidney.BIO a public or private company?
LiveKidney.BIO is a private company.
What is the current stock price of LiveKidney.BIO?
LiveKidney.BIO is a private company, so its shares have no public market price. Caplight tracks LiveKidney.BIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LiveKidney.BIO worth (valuation)?
Valuation information for LiveKidney.BIO is not publicly available.
Can I buy LiveKidney.BIO stock?
LiveKidney.BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LiveKidney.BIO's last funding round?
LiveKidney.BIO's most recent funding round was Seed on November 18, 2018.
Who are the main investors in LiveKidney.BIO?
Key investors in LiveKidney.BIO include Direct Insurance - Financial Investments, Aurum Ventures MKI.
Will LiveKidney.BIO IPO soon?
No public IPO plans have been announced for LiveKidney.BIO.
How can I track LiveKidney.BIO secondary market activity?
Caplight tracks bids, offers, and trades in LiveKidney.BIO's shares on secondary markets.